Circulating microRNAs are associated with docetaxel chemotherapy outcome in castration-resistant prostate cancer

被引：0
|
作者：
H-M Lin
L Castillo
K L Mahon
K Chiam
B Y Lee
Q Nguyen
M J Boyer
M R Stockler
N Pavlakis
G Marx
G Mallesara
H Gurney
S J Clark
A Swarbrick
R J Daly
L G Horvath
机构：
[1] The Kinghorn Cancer Centre/Garvan Institute of Medical Research,Cancer Research Division
[2] Sydney Medical School,Department of Medical Oncology
[3] University of Sydney,undefined
[4] Pharmacogenomic Research for Individualised Medicine (PRIMe) consortium,undefined
[5] Chris O’Brien Lifehouse,undefined
[6] Royal Prince Alfred Hospital,undefined
[7] Medical Oncology,undefined
[8] Concord Repatriation General Hospital,undefined
[9] Concord,undefined
[10] Medical Oncology,undefined
[11] Royal North Shore Hospital,undefined
[12] Northern Haematology and Oncology Group,undefined
[13] Sydney Adventist Hospital,undefined
[14] Calvary Mater Newcastle Hospital,undefined
[15] Westmead Hospital,undefined
[16] St Vincent’s Clinical School,undefined
[17] Faculty of Medicine,undefined
[18] UNSW Australia,undefined
[19] Signalling Network Laboratory,undefined
[20] School of Biomedical Sciences,undefined
[21] Monash University,undefined
来源：
British Journal of Cancer | 2014年 / 110卷
关键词：
circulating microRNAs; chemotherapy; metastatic prostate cancer; biomarkers; docetaxel;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2462 / 2471
页数：9
相关论文
共 50 条
  • [41] Docetaxel with or without zoledronic acid for castration-resistant prostate cancer
    Yue Pan
    Haiyong Jin
    Wei Chen
    Zhixian Yu
    Tingyu Ye
    Yuancai Zheng
    Zhiliang Weng
    Feng Wang
    International Urology and Nephrology, 2014, 46 : 2319 - 2326
  • [42] Docetaxel with or without zoledronic acid for castration-resistant prostate cancer
    Pan, Yue
    Jin, Haiyong
    Chen, Wei
    Yu, Zhixian
    Ye, Tingyu
    Zheng, Yuancai
    Weng, Zhiliang
    Wang, Feng
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2014, 46 (12) : 2319 - 2326
  • [43] Docetaxel in combination with estramustine and prednisolone for castration-resistant prostate cancer
    Kuramoto, Tomomi
    Inagaki, Takeshi
    Fujii, Reona
    Sasaki, Yumiko
    Nishizawa, Satoshi
    Nanpo, Yoshihito
    Matusmura, Nagahide
    Kohjimoto, Yasuo
    Hara, Isao
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2013, 18 (05) : 890 - 897
  • [44] Management of metastatic castration-resistant prostate cancer following docetaxel
    Beuzeboc, Philippe
    Ropert, Stanislas
    Goldwasser, Francois
    Zerbib, Marc
    BULLETIN DU CANCER, 2012, 99 : S66 - S72
  • [45] Docetaxel in combination with estramustine and prednisolone for castration-resistant prostate cancer
    Tomomi Kuramoto
    Takeshi Inagaki
    Reona Fujii
    Yumiko Sasaki
    Satoshi Nishizawa
    Yoshihito Nanpo
    Nagahide Matusmura
    Yasuo Kohjimoto
    Isao Hara
    International Journal of Clinical Oncology, 2013, 18 : 890 - 897
  • [46] Low-dose docetaxel, estramustine and prednisolone combination chemotherapy for castration-resistant prostate cancer
    Nakano, Mayura
    Shoji, Sunao
    Higure, Taro
    Kawakami, Masayoshi
    Tomonaga, Tetsuro
    Terachi, Toshiro
    Uchida, Toyoaki
    MOLECULAR AND CLINICAL ONCOLOGY, 2016, 4 (06) : 942 - 946
  • [47] Risk factors for febrile neutropenia in patients receiving docetaxel chemotherapy for castration-resistant prostate cancer
    Masaki Shiota
    Akira Yokomizo
    Ario Takeuchi
    Keijiro Kiyoshima
    Junichi Inokuchi
    Katsunori Tatsugami
    Seiji Naito
    Supportive Care in Cancer, 2014, 22 : 3219 - 3226
  • [48] A case of castration-resistant prostate cancer with liver metastases achieved a complete response by docetaxel chemotherapy
    Shirotake, Suguru
    Umezawa, Yuta
    Okabe, Takashi
    Kaneko, Go
    Kanao, Kent
    Nishimoto, Koshiro
    Oyama, Masafumi
    TRANSLATIONAL ANDROLOGY AND UROLOGY, 2020, 9 (02) : 819 - 823
  • [49] Exosomal microRNAs as Potential Biomarkers in Castration-resistant Prostate Cancer
    Haflidadottir, Benedikta S.
    Ceder, Yvonne
    EUROPEAN UROLOGY, 2015, 67 (01) : 42 - 43
  • [50] Docetaxel-Based Systemic Chemotherapy in Elderly Korean Men With Castration-Resistant Prostate Cancer
    Park, S. C. H.
    Whan, L. J.
    Sik, R. J.
    ACTAS UROLOGICAS ESPANOLAS, 2012, 36 (07): : 425 - 430
12345